Table 6.
IFN-γ genotype and allele frequency for patients with GDM.
| IFN-γ loci | Control group ( N = 280) | GDM group ( N = 160) | OR (95% CI) a | p a | ||
|---|---|---|---|---|---|---|
| n | Percentage (%) | n | Percentage (%) | |||
| +874 A/T | ||||||
| AA | 151 | 53.9 | 79 | 49.4 | 1.00REF | |
| AT | 112 | 40.0 | 60 | 37.5 | 1.02 (0.68–1.55) | 0.911 |
| TT | 17 | 6.1 | 21 | 13.1 | 2.36 (1.18–4.73) | 0.014 |
| A | 414 | 73.9 | 218 | 68.1 | 1.00REF | |
| T | 146 | 26.1 | 102 | 31.9 | 1.33 (0.98–1.79) | 0.066 |
| +2108 A/G | ||||||
| AA | 143 | 51.1 | 80 | 50.0 | 1.00REF | |
| AG | 112 | 40.0 | 66 | 41.3 | 1.05 (0.70–1.59) | 0.803 |
| GG | 25 | 8.9 | 14 | 8.7 | 1.00 (0.49–2.03) | 0.998 |
| A | 398 | 71.1 | 226 | 70.6 | 1.00REF | |
| G | 162 | 28.9 | 94 | 29.4 | 1.02 (0.76–1.38) | 0.888 |
Note: The bolded data are significant in terms of statistics. “REF” represents “reference group.”
Abbreviations: CI, confidence interval; GDM, gestational diabetes mellitus; OR, odds ratio.
aAdjusted for sex and age by logistic regression model.